Biologic
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Childhood Acute Lymphoblastic Leukemia in Remission · Childhood Acute Myeloid Leukemia in Remission · Myelodysplastic Syndromes
Enrolment: 27 · Results not recorded
Myasthenia Gravis
Enrolment: 9 · Results not recorded
Acute Leukemia in Remission · Myelodysplastic Syndromes · Multiple Myeloma
Enrolment: 32 · Results not recorded
Myeloma
Enrolment: 30 · Results not recorded
Beta Thalassemia Major · Congenital Anemias
Enrolment: 5 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Established neonatal mouse model of excitotoxic brain injury mediated by N-methyl-D-aspartate receptor activation
Delayed intraperitoneal G-CSF/SCF and FL significantly reduced lesion size at postnatal days 10, 18 and 90. G-CSF/SCF reduced caspase-3 activation, while neither treatment affected apoptosis-inducing factor dependent apoptosis or cell proliferation.
Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.
